ELEVEN BIOTHERAPEUTICS INC's ticker is EBIO and the CUSIP is 286221106. A total of 25 filers reported holding ELEVEN BIOTHERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $459,000 | +73.2% | 437,110 | +33.7% | 0.00% | – |
| Q4 2017 | $265,000 | -8.9% | 326,883 | +77.4% | 0.00% | – |
| Q3 2017 | $291,000 | -10.2% | 184,304 | -10.7% | 0.00% | – |
| Q2 2017 | $324,000 | -16.1% | 206,450 | +17.4% | 0.00% | – |
| Q1 2017 | $386,000 | +67.1% | 175,850 | +45.1% | 0.00% | – |
| Q4 2016 | $231,000 | -27.6% | 121,156 | +6.6% | 0.00% | – |
| Q3 2016 | $319,000 | +145.4% | 113,656 | +46.4% | 0.00% | – |
| Q2 2016 | $130,000 | +420.0% | 77,656 | 0.0% | 0.00% | – |
| Q1 2016 | $25,000 | -95.9% | 77,656 | -62.0% | 0.00% | – |
| Q4 2015 | $614,000 | -99.6% | 204,207 | -95.7% | 0.00% | -100.0% |
| Q3 2015 | $150,621,000 | +47265.1% | 4,748,330 | +4112.1% | 0.01% | – |
| Q2 2015 | $318,000 | -65.0% | 112,732 | +10.7% | 0.00% | – |
| Q1 2015 | $908,000 | -19.6% | 101,807 | +7.1% | 0.00% | – |
| Q4 2014 | $1,130,000 | +7.4% | 95,057 | +0.6% | 0.00% | – |
| Q3 2014 | $1,052,000 | -7.6% | 94,482 | +9.3% | 0.00% | – |
| Q2 2014 | $1,139,000 | -19.2% | 86,462 | -0.5% | 0.00% | – |
| Q1 2014 | $1,410,000 | – | 86,887 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|